NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 137 filers reported holding NEKTAR THERAPEUTICS in Q3 2023. The put-call ratio across all filers is 5.78 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,422 | +3.5% | 15,820 | 0.0% | 0.00% | – |
| Q2 2023 | $9,100 | -18.2% | 15,820 | 0.0% | 0.00% | – |
| Q1 2023 | $11,120 | -70.7% | 15,820 | -5.9% | 0.00% | -100.0% |
| Q4 2022 | $37,997 | -33.3% | 16,813 | -6.2% | 0.00% | -33.3% |
| Q3 2022 | $57,000 | -14.9% | 17,916 | +1.3% | 0.00% | 0.0% |
| Q2 2022 | $67,000 | -28.7% | 17,678 | +4.3% | 0.00% | -25.0% |
| Q1 2022 | $94,000 | -60.3% | 16,943 | -3.3% | 0.00% | -55.6% |
| Q4 2021 | $237,000 | -23.1% | 17,523 | +2.0% | 0.01% | -25.0% |
| Q3 2021 | $308,000 | +6.9% | 17,173 | +2.2% | 0.01% | 0.0% |
| Q2 2021 | $288,000 | -14.5% | 16,796 | -0.3% | 0.01% | -25.0% |
| Q1 2021 | $337,000 | +18.2% | 16,840 | +0.3% | 0.02% | +6.7% |
| Q4 2020 | $285,000 | 0.0% | 16,782 | -2.4% | 0.02% | -16.7% |
| Q3 2020 | $285,000 | -22.8% | 17,187 | +7.7% | 0.02% | -25.0% |
| Q2 2020 | $369,000 | +29.5% | 15,955 | -0.3% | 0.02% | +4.3% |
| Q1 2020 | $285,000 | -16.2% | 16,000 | +1.7% | 0.02% | -11.5% |
| Q4 2019 | $340,000 | +19.3% | 15,735 | +0.5% | 0.03% | +8.3% |
| Q3 2019 | $285,000 | -48.8% | 15,659 | 0.0% | 0.02% | -55.6% |
| Q2 2019 | $557,000 | +6.3% | 15,659 | +0.4% | 0.05% | -8.5% |
| Q1 2019 | $524,000 | +2.3% | 15,600 | 0.0% | 0.06% | -16.9% |
| Q4 2018 | $512,000 | -46.2% | 15,600 | 0.0% | 0.07% | -39.8% |
| Q3 2018 | $951,000 | +24.6% | 15,600 | -0.2% | 0.12% | +8.3% |
| Q2 2018 | $763,000 | -53.8% | 15,635 | +0.5% | 0.11% | -57.8% |
| Q1 2018 | $1,652,000 | – | 15,550 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 3,500,000 | $60,060,000 | 2.02% |
| ACT CAPITAL MANAGEMENT, LLC | 161,500 | $2,772,000 | 1.42% |
| Rhenman & Partners Asset Management AB | 950,000 | $16,302,000 | 1.11% |
| MAVERICK CAPITAL LTD | 5,761,073 | $98,860,000 | 0.93% |
| Birchview Capital, LP | 72,000 | $1,236,000 | 0.74% |
| Bellevue Group AG | 4,101,404 | $70,380,000 | 0.69% |
| CM Management, LLC | 50,000 | $858,000 | 0.62% |
| Duquesne Family Office | 1,000,000 | $17,160,000 | 0.42% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 373,368 | $6,407,000 | 0.33% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 67,000 | $1,149,000 | 0.30% |